All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

121

Reset

121 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • C2402Not ApplicablePhase 31 trial

    JW Pharmaceutical · Hypertension, Dyslipidemia

  • C2403Phase 31 trial

    JW Pharmaceutical · Hypertension, Dyslipidemia

  • C52R1LPhase 31 trial

    AJU Pharm Co., Ltd. · Essential Hypertension

  • C52R1MPhase 31 trial

    AJU Pharm Co., Ltd. · Essential Hypertension

  • DWC202313Phase 31 trial

    Daewoong Pharmaceutical Co. LTD. · Essential Hypertension

  • DWC202404Phase 31 trial

    Daewoong Pharmaceutical Co. LTD. · Hypertension, Essential Hypertension

  • DWC202405Phase 31 trial

    Daewoong Pharmaceutical Co. LTD. · Essential Hypertension

  • FimasartanPhase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • HCP1803-4Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Hypertension

  • HGP2304-1Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Hypertension

  • HGP2304-2Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Hypertension

  • HPP2002-1Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Hypertension

  • HPP2003-3Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Hypertension

  • JW0104Phase 31 trial

    JW Pharmaceutical · Hypertension, Dyslipidemia

  • L606Treprostinil LiposomePhase 31 trial

    Liquidia Technologies, Inc. · Pulmonary Hypertension Due to Lung Disease (Disorder)

  • OPC-1085ELPhase 31 trial

    Otsuka · Open Angle Glaucoma or Ocular Hypertension

  • QR12000Phase 31 trial

    Wuhan Createrna Science and Technology Co., Ltd · Essential Hypertension

  • RLD2001-2Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Hypertension

  • RLD2209-1Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Hypertension

  • RLD2209-2Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Hypertension

  • SYH9056Phase 31 trial

    CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Mild-to-moderate Essential Hypertension

  • TCA108Phase 31 trial

    EMS · Hypertension

  • THP-00101Forxiga Tab.Phase 31 trial

    THPharm Corp. · Type 2 Diabetes, Hypertension

  • THP-00102Micardis Tab., THP-00103Phase 31 trial

    THPharm Corp. · Type 2 Diabetes, Hypertension

  • THP-00104Phase 31 trial

    THPharm Corp. · Type 2 Diabetes, Hypertension

  • THP-00105Phase 31 trial

    THPharm Corp. · Type 2 Diabetes, Hypertension

  • THP-00106Phase 31 trial

    THPharm Corp. · Type 2 Diabetes, Hypertension

  • QCZ484Phase 23 trials

    Novartis · Hypertension (HTN), Hypertension, Hypercholesterolaemia

  • QLS-111Phase 23 trials

    Qlaris Bio, Inc. · Normal Tension Glaucoma (NTG), Glaucoma, Open-angle Glaucoma (OAG)

  • SAL0140Phase 23 trials

    Shenzhen Salubris Pharmaceuticals Co., Ltd. · Primary Aldosteronism, Chronic Kidney Disease, Uncontrolled Hypertension

  • GW906Phase 22 trials

    Shenzhen Salubris Pharmaceuticals Co., Ltd. · Hypertension

  • HS235Phase 22 trials

    35Pharma Inc., a GSK company · Pulmonary Arterial Hypertension, Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction

  • LAM-001Phase 22 trials

    IRulya Therapeutics Inc. · Sarcoidosis Associated Pulmonary Hypertension, Pulmonary Hypertension Due to Lung Diseases and Hypoxia

  • NS-863Phase 22 trials

    NS Pharma, Inc. · Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD), Pulmonary Arterial Hypertension

  • of QLS1410Phase 22 trials

    Qilu Pharmaceutical Co., Ltd. · Hypertension (HTN), Uncontrolled Hypertension

  • SYH2072Phase 22 trials

    InnovStone Therapeutics Limited · Uncontrolled Hypertension, Resistant Hypertension, Primary Aldosteronism

  • TonlamarsenPhase 22 trials

    Kardigan, Inc. · Hypertension, Acute Severe Hypertension, Hypertensive Emergency

  • TX000045Phase 22 trials

    Tectonic Therapeutic · Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction, Hypertension, Pulmonary

  • AGN-193408Phase 21 trial

    AbbVie · Open-angle Glaucoma, Ocular Hypertension

  • APL-9796Phase 21 trial

    Apollo Therapeutics Ltd · Pulmonary Arterial Hypertension

  • AR-17043Phase 21 trial

    Alcon Research · Open Angle Glaucoma, Ocular Hypertension

  • AZD3427Phase 21 trial

    AstraZeneca · Pulmonary Hypertension (World Health Organization Group 2), Heart Failure

  • BEBT-701Phase 21 trial

    BeBetter Med Inc · Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol

  • BR1400-1Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BR1400-2Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BR1400-3Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BR1400-4Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BR1400-5Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BR1400-APhase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BR1400-BPhase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

NewerPage 2 of 3Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.